NEW YORK-- Shares of Amag Pharmaceuticals Inc. sank Wednesday after the company said it is taking a batch of its anemia drug Feraheme off the market following the death of a patient. THE SPARK: Amag said its partner Takeda Pharmaceutical is taking a batch of the drug off the market in Switzerland.
Some of the names on the move ahead of the open.
And I'm caught one more time Up on Cyprus Avenue -Van Morrison, "Cyprus Avenue"
*VIX, Wall St's fear gauge, scores biggest jump since Aug. 18, 2011. NEW YORK, Feb 25- U.S. stocks on Monday suffered their biggest drop since November after a strong showing in Italian elections by groups opposed to the country's economic reforms triggered worry that Europe's debt problems could once again destabilize the global economy.
*Barnes& Noble rallies as chairman offers to buy part of it. NEW YORK, Feb 25- U.S. stocks fell on Monday, reversing course from earlier gains as elections in Italy stoked concerns a divided parliament could disrupt the country's fiscal reforms and the euro zone's stability.
TOKYO/ WASHINGTON, Feb 24- U.S.-based Affymax Inc and Japan's Takeda Pharmaceutical Co said they are voluntarily recalling all lots of anemia treatment Omontys in the United States due to reports of serious hypersensitivity reactions, including some deaths.
TheStreet.com details the 10 best-performing biopharmaceutical stocks of 2012 and their outlook for 2013.